News: Press Releases

Press Releases
Kane Biotech Announces Second Closing of Private Placement Offering and Resignation of Director

Kane Biotech Announces Second Closing of Private Placement Offering and Resignation of Director

WINNIPEG, Manitoba – August 18, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it has completed the…

> Read More

Press Releases
Kane Biotech – Q2 2017 Financial Results

WINNIPEG, Manitoba – (GlobalNewsWired – August 16, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q2 2017 Financial Results.

Highlights:

Total Revenues:

For the six months ended June 30, 2017 were $890,906, an…

> Read More

Press Releases
Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options

Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options

WINNIPEG, Manitoba – (Marketwired – July 24, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced it has paid out all…

> Read More

Press Releases
Kane Biotech Announces Closing of Over-Sold Private Placement Offering

Kane Biotech Announces Closing of Over-Sold Private Placement Offering

WINNIPEG, Manitoba – July 17, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it has closed its previously announced private placement offering (the “Offering”) of…

> Read More

Press Releases
Kane Biotech Announces Closing of Loan Transaction

WINNIPEG, Manitoba – (Marketwired – June 27, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it has received a loan (the “Loan”) in the amount of $400,000 from Individual Investment Corporation, an arm’s length…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering

WINNIPEG, Manitoba – (Marketwired – June 1, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 33,333,333 units (“Units”)…

> Read More

Press Releases
Kane Biotech – Q1 2017 Financial Results

WINNIPEG, Manitoba – (Marketwired – May 17, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q1 2017 Financial Results.

Highlights:

Total Revenue during the quarter ended March 31, 2017 was $784,900, an…

> Read More

Press Releases
Kane Biotech – Business and Intellectual Property Update

WINNIPEG, Manitoba – (Marketwired – May 11, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to provide an update on its business activities and intellectual property achievements.

The Corporation continues to focus the majority of…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – March 27, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on March 27, 2017, it issued 80,251 common shares of the Corporation (“Common Shares”) in payment of $12,439 in interest owing on the Corporation’s $500,000…

> Read More

Press Releases
Kane Biotech Announces Completion of Share Consolidation

WINNIPEG, Manitoba – March 10, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that, further to the approval by the Corporation’s shareholders obtained on December 16, 2016, the Corporation has completed the consolidation of its…

> Read More